Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 10,400
-920 (-8.13%)
Oct 12, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 255.27 billion as of October 12, 2026. It is the 21,009th most valuable company in the world and the 717th biggest in South Korea. Its market cap has decreased by 47.25% in one year.
Market Cap
255.27B
Enterprise Value
176.42B
Revenue
2.95B
Global Rank
Country Rank
#717 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 255.27B, an increase of 332.67%. That is a compound annual growth rate of 16.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 255.27B | -61.29% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Corp. | 443.05B |
| Medy-Tox | 425.60B |
| Orum Therapeutics | 419.18B |
| MEDIPOST | 374.83B |
| SillaJen | 324.22B |
| HLB Therapeutics | 279.84B |
| GC Genome | 233.43B |
| GC Cell | 219.40B |